Protocols
3 protocol(s) meet the specified criteria
PI: Foster, Matthew
Protocol No.TitleStatus
A041501-CIRBA Phase III Trial To Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (A Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39) with Newly Diagnosed Precursor B-Cell ALLOpen
LCCC1541-ATLAdministration of autologous CAR-T cells targeting the CD19 antigen and containing the inducible caspase9 safety switch in patients with relapsed/refractory Acute Lymphoblastic Leukemia Open
LCCC1830-ATL-COMCompassionate use administration of autologous CAR T cells targeting the CD19 antigen and containing the inducible caspase 9 safety switchOpen